These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 8626427)

  • 1. The unique nature of the serine interactions for alpha 1-adrenergic receptor agonist binding and activation.
    Hwa J; Perez DM
    J Biol Chem; 1996 Mar; 271(11):6322-7. PubMed ID: 8626427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ser203 as well as Ser204 and Ser207 in fifth transmembrane domain of the human beta2-adrenoceptor contributes to agonist binding and receptor activation.
    Sato T; Kobayashi H; Nagao T; Kurose H
    Br J Pharmacol; 1999 Sep; 128(2):272-4. PubMed ID: 10510435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of critical determinants of alpha 1-adrenergic receptor subtype selective agonist binding.
    Hwa J; Graham RM; Perez DM
    J Biol Chem; 1995 Sep; 270(39):23189-95. PubMed ID: 7559466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential contribution of two serine residues of wild type and constitutively active beta2-adrenoceptors to the interaction with beta2-selective agonists.
    Kikkawa H; Kurose H; Isogaya M; Sato Y; Nagao T
    Br J Pharmacol; 1997 Jul; 121(6):1059-64. PubMed ID: 9249239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel aromatic residues in transmembrane domains IV and V involved in agonist binding at alpha(1a)-adrenergic receptors.
    Waugh DJ; Zhao MM; Zuscik MJ; Perez DM
    J Biol Chem; 2000 Apr; 275(16):11698-705. PubMed ID: 10766790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms of ligand-receptor interactions in transmembrane domain V of the alpha2A-adrenoceptor.
    Peltonen JM; Nyrönen T; Wurster S; Pihlavisto M; Hoffrén AM; Marjamäki A; Xhaard H; Kanerva L; Savola JM; Johnson MS; Scheinin M
    Br J Pharmacol; 2003 Sep; 140(2):347-58. PubMed ID: 12970108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amino acids of the human alpha1d-adrenergic receptor involved in antagonist binding.
    Nagaoka Y; Ahmed M; Hossain M; Bhuiyan MA; Ishiguro M; Nakamura T; Watanabe M; Nagatomo T
    J Pharmacol Sci; 2008 Jan; 106(1):114-20. PubMed ID: 18187928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Site-directed mutagenesis of alpha 2A-adrenergic receptors: identification of amino acids involved in ligand binding and receptor activation by agonists.
    Wang CD; Buck MA; Fraser CM
    Mol Pharmacol; 1991 Aug; 40(2):168-79. PubMed ID: 1678850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligand recognition of serine-cysteine amino acid exchanges in transmembrane domain 5 of alpha2-adrenergic receptors by UK 14,304.
    Cockcroft V; Frang H; Pihlavisto M; Marjamäki A; Scheinin M
    J Neurochem; 2000 Apr; 74(4):1705-10. PubMed ID: 10737629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chimeras of alpha1-adrenergic receptor subtypes identify critical residues that modulate active state isomerization.
    Hwa J; Graham RM; Perez DM
    J Biol Chem; 1996 Apr; 271(14):7956-64. PubMed ID: 8626475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of norepinephrine on rat cultured microglial cells that express alpha1, alpha2, beta1 and beta2 adrenergic receptors.
    Mori K; Ozaki E; Zhang B; Yang L; Yokoyama A; Takeda I; Maeda N; Sakanaka M; Tanaka J
    Neuropharmacology; 2002 Nov; 43(6):1026-34. PubMed ID: 12423672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of two serine residues involved in agonist activation of the beta-adrenergic receptor.
    Strader CD; Candelore MR; Hill WS; Sigal IS; Dixon RA
    J Biol Chem; 1989 Aug; 264(23):13572-8. PubMed ID: 2547766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Four consecutive serines in the third intracellular loop are the sites for beta-adrenergic receptor kinase-mediated phosphorylation and desensitization of the alpha 2A-adrenergic receptor.
    Eason MG; Moreira SP; Liggett SB
    J Biol Chem; 1995 Mar; 270(9):4681-8. PubMed ID: 7876239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disparate ligand-mediated Ca(2+) responses by wild-type, mutant Ser(200)Ala and Ser(204)Ala alpha(2A)-adrenoceptor: G(alpha15) fusion proteins: evidence for multiple ligand-activation binding sites.
    Pauwels PJ; Colpaert FC
    Br J Pharmacol; 2000 Aug; 130(7):1505-12. PubMed ID: 10928951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in the NPxxY motif stabilize pharmacologically distinct conformational states of the α
    Ragnarsson L; Andersson Å; Thomas WG; Lewis RJ
    Sci Signal; 2019 Mar; 12(572):. PubMed ID: 30862702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The presence of beta2-adrenoceptors sensitizes alpha2A-adrenoceptors to desensitization after chronic epinephrine treatment.
    Bawa-Khalfe T; Altememi GF; Mandyam CD; Schwarz LA; Eikenburg DC; Standifer KM
    BMC Pharmacol; 2007 Dec; 7():16. PubMed ID: 18096057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanism for agonist-promoted alpha(2A)-adrenoceptor activation by norepinephrine and epinephrine.
    Nyrönen T; Pihlavisto M; Peltonen JM; Hoffrén AM; Varis M; Salminen T; Wurster S; Marjamäki A; Kanerva L; Katainen E; Laaksonen L; Savola JM; Scheinin M; Johnson MS
    Mol Pharmacol; 2001 May; 59(5):1343-54. PubMed ID: 11306720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of critical extracellular loop residues involved in alpha 1-adrenergic receptor subtype-selective antagonist binding.
    Zhao MM; Hwa J; Perez DM
    Mol Pharmacol; 1996 Nov; 50(5):1118-26. PubMed ID: 8913343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dominant-negative activity of an alpha(1B)-adrenergic receptor signal-inactivating point mutation.
    Chen S; Lin F; Xu M; Hwa J; Graham RM
    EMBO J; 2000 Aug; 19(16):4265-71. PubMed ID: 10944109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serine 232 of the alpha(2A)-adrenergic receptor is a protein kinase C-sensitive effector coupling switch.
    Liang M; Freedman NJ; Theiss CT; Liggett SB
    Biochemistry; 2001 Dec; 40(49):15031-7. PubMed ID: 11732925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.